Cudratricusxanthone A exhibits antitumor activity and enhances chemosensitivity to cisplatin against NSCLC via targeting EGFR

Abstract Non-small cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancer cases and has gained considerable global attention. Epidermal growth factor receptor (EGFR) plays a key role in NSCLC treatment. NSCLC with wild-type EGFR (WT-EGFR) is not responsive to EGFR tyrosine kinase...

Полное описание

Библиографические подробности

Главные авторы:	Peiyuan Sun, Zhuoyi Wang, Ruohan Zhang, Xuanyou Li, Boxing Xu, Rui Shen, Jun Sheng, Jing Wang
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Nature Portfolio 2025-08-01
Серии:	Scientific Reports
Предметы:	NSCLC EGFR Cudratricusxanthone A Antitumor Chemosensitivity
Online-ссылка:	https://doi.org/10.1038/s41598-025-14889-x
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!